VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 112 filers reported holding VOYAGER THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.20 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,154,000 | -38.7% | 438,767 | -3.7% | 0.01% | -38.5% |
| Q2 2021 | $1,882,000 | -28.8% | 455,663 | -18.9% | 0.01% | -35.0% |
| Q1 2021 | $2,645,000 | +240.0% | 561,669 | +416.3% | 0.02% | +185.7% |
| Q4 2020 | $778,000 | -12.7% | 108,784 | +30.2% | 0.01% | -22.2% |
| Q3 2020 | $891,000 | +11.8% | 83,545 | +32.3% | 0.01% | 0.0% |
| Q2 2020 | $797,000 | +486.0% | 63,126 | +323.6% | 0.01% | +350.0% |
| Q1 2020 | $136,000 | -22.3% | 14,901 | +19.1% | 0.00% | 0.0% |
| Q4 2019 | $175,000 | -78.7% | 12,510 | -73.7% | 0.00% | -80.0% |
| Q3 2019 | $820,000 | +0.6% | 47,630 | +59.1% | 0.01% | -9.1% |
| Q2 2019 | $815,000 | -26.8% | 29,940 | -48.5% | 0.01% | -31.2% |
| Q1 2019 | $1,113,000 | +328.1% | 58,145 | +337.2% | 0.02% | +300.0% |
| Q2 2018 | $260,000 | – | 13,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $109,992,000 | 62.32% |
| Foresite Capital Management IV, LLC | 830,565 | $14,294,000 | 4.62% |
| Casdin Capital, LLC | 1,128,075 | $19,414,171,000 | 2.01% |
| ARMISTICE CAPITAL, LLC | 1,096,000 | $18,862,000 | 1.25% |
| Bellevue Group AG | 2,704,683 | $46,548,000 | 0.87% |
| PFM Health Sciences, LP | 1,231,954 | $21,202,000 | 0.63% |
| Boxer Capital, LLC | 500,000 | $8,605,000 | 0.62% |
| Aevitas Wealth Management, Inc. | 23,150 | $398,000 | 0.40% |
| 361 CAPITAL LLC | 120,143 | $2,068,000 | 0.38% |
| Birchview Capital, LP | 30,000 | $516,000 | 0.34% |